Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COM
-
Number of holders
-
783
-
Total 13F shares, excl. options
-
95.1M
-
Shares change
-
+1.02M
-
Total reported value, excl. options
-
$15.4B
-
Value change
-
+$165M
-
Put/Call ratio
-
1.02
-
Number of buys
-
342
-
Number of sells
-
-319
-
Price
-
$161.75
Significant Holders of Labcorp Hldgs Inc. - COM (LH) as of Q1 2018
847 filings reported holding LH - Labcorp Hldgs Inc. - COM as of Q1 2018.
Labcorp Hldgs Inc. - COM (LH) has 783 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 95.1M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (10.7M shares), BlackRock Inc. (7.98M shares), Boston Partners (5.67M shares), STATE STREET CORP (4.13M shares), NORDEA INVESTMENT MANAGEMENT AB (2.17M shares), GLENVIEW CAPITAL MANAGEMENT, LLC (1.86M shares), IRIDIAN ASSET MANAGEMENT LLC/CT (1.69M shares), UBS ASSET MANAGEMENT AMERICAS INC (1.66M shares), GOLDMAN SACHS GROUP INC (1.63M shares), and DIMENSIONAL FUND ADVISORS LP (1.43M shares).
This table shows the top 783 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.